| Identifier |
20220215_nanos_sciplatform2_03 |
| Title |
A Randomized Controlled, Trial of the GLP-1 Receptor Agonist Exenatide in Idiopathic Intracranial Hypertension |
| Creator |
James Mitchell, Major RAMC |
| Affiliation |
University of Birmingham, England |
| Subject |
Pseudotumor Cerebri; High Intracranial Pressure/Headache |
| Description |
Pre-clinical data demonstrates the ability of Exenatide, a GLP-1R agonist, to reduce CSF secretion and ICP.1 Existing GLP- 1R agonists are widely used to treat obesity and diabetes (but do not cause hypoglycaemia). |
| Date |
2022-02 |
| Language |
eng |
| Format |
application/pdf |
| Format Creation |
Microsoft PowerPoint |
| Type |
Text |
| Source |
2022 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS Annual Meeting 2022: Scientific Platform Session II |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2022. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s68nevjr |
| Setname |
ehsl_novel_nam |
| ID |
2191976 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s68nevjr |
